Inaugural Class of Avon Global Breast Cancer Clinical Scholars Arrive in U.S. to Learn Advanced Skills and Techniques to help Women in Home Countries

25 Avon Global Scholars Training at Leading Avon Foundation-funded Breast Cancer Centers Across United States

NEW YORK, NY (Oct. 2, 2012) – In recognition of the 20th Anniversary of the Avon Breast Cancer Crusade, the Avon Foundation for Women welcomed its first class of 25 Avon Global Breast Cancer Clinical Scholars from 14 countries to the United States at the at the 2012 Breast Cancer Symposium. The Avon Scholars program is Avon’s first solely-run global initiative to educate doctors to help reduce the unacceptably high mortality rates from breast cancer in many countries around the world.

The Avon Global Scholars Program—first announced by Reese Witherspoon last October during the 2011 Breast Cancer Global Congressisproviding clinically-focused scholarship opportunities for breast cancer specialists from outside the United States to receive advanced training at one of 13 Avon Foundation-funded leading U.S. breast cancer centers.
The Avon Foundation Scientific Advisory Board and host institution mentors evaluated the applications and their recommendations were sent to the Avon Foundation Board of Directors who made the final scholar selections.

Following their attendance at the 2012 Breast Cancer Symposium in mid-September, the Avon Scholars began a four to eight-week intensive training in breast cancer surgery, pathology, breast imaging (radiology), medical oncology, clinical trial design and community and public health. Avon’s goal is for the scholars to return home with advanced skills and cutting edge information so they are better equipped to provide the highest quality of breast cancer care to patients in their home countries.

“The Avon Global Breast Cancer Clinical Scholars are receiving training from some of the best breast cancer doctors in the United States. They are training at institutions the Avon Foundation has chosen to fund because of their excellence and advancements in breast cancer research, treatment and access to care,” said Marc Hurlbert, PhD, executive director of the Avon Foundation Breast Cancer Crusade. “This first set of Avon Scholars can help literally tens of thousands of women through patient care, as well as by sharing their knowledge and expertise with their colleagues at home.”

The first Avon Scholars class includes breast cancer specialists from Armenia, Brazil, China, Colombia, Croatia, India, Kenya, Nigeria, Philippines, Serbia, Turkey, Ukraine, Venezuela and Zambia and will be studying at the following Avon Foundation-funded breast cancer programs:

  • Boston Medical Center, Boston, MA (1 Scholar)
  • Emory University-Grady Memorial Hospital, Atlanta, GA (2 Scholars)
  • Georgetown University-Capital Breast Care Center, Washington DC (2 Scholars)
  • Johns Hopkins University, Baltimore, MD (2 Scholars)
  • Magee - Women's Hospital, University of Pittsburgh, Pittsburgh, PA (2 Scholars)
  • Massachusetts General Hospital, Boston, MA (2 Scholars)
  • New York University-Bellevue Hospital, New York, NY (2 Scholars)
  • New York-Presbyterian Hospital-Columbia University Medical Center, New York, NY (2 Scholars)
  • Northwestern University, Chicago, IL (2 Scholars)
  • Sinai Urban Health Institute, Chicago, IL (2 Scholars)
  • University of California Los Angeles-Olive View Medical Center, Los Angeles, CA (2 Scholars)
  • University of California San Francisco-San Francisco General Hospital, San Francisco, CA (2 Scholars)
  • Washington University St. Louis, St. Louis, MO (2 Scholars)

After the Avon Scholars complete their studies, the Avon Foundation will work with the scholars and mentors to assess the program to determine if and when it will issue a second call-for-applications.

About the Avon Breast Cancer Crusade
The Avon Breast Cancer Crusade, which observes its 20th anniversary in 2012, has placed Avon at the forefront of the fight against breast cancer. Today, Avon is the leading corporate supporter of the cause globally. In the 20 years since the Crusade’s launch, Avon breast cancer programs in 58 countries have donated more than $780 million for research and advancing access to care, regardless of a person’s ability to pay. Avon awards funding to beneficiaries ranging from leading cancer centers to community-based grassroots breast health programs to support breast cancer research and access to care. The Crusade has enabled more than 17 million women globally to receive free mammograms and breast cancer screenings, educated more than 100 million women about breast cancer, and funded promising research into the causes of breast cancer and ways to prevent the disease. Avon raises funds for the Crusade through the sale of Avon “Pink Ribbon” products and through fundraising events in more than 50 countries annually, including the U.S. Avon Walk for Breast Cancer series and Avon Walk Around the World for Breast Cancer events.

###